Protective capacity of proteoliposomes fromMycobacterium bovisBCG in a mouse model of tuberculosis

Progress in tuberculosis vaccine development and host-directed therapies—a state of the art review

(2014) Stefan H E Kaufmann et al.   Lancet Respiratory Medicine

Budesonide suppresses pulmonary antibacterial host defense by down-regulating cathelicidin-related antimicrobial peptide in allergic inflammation mice and in lung epithelial cells

(2013) Peng Wang et al.   BMC IMMUNOLOGY

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial

(2013) Michele D Tameris et al.   LANCET

WHO's 2013 global report on tuberculosis: successes, threats, and opportunities

(2013) Alimuddin Zumla et al.   LANCET

Tuberculosis

(2013) Alimuddin Zumla et al.   NEW ENGLAND JOURNAL OF MEDICINE

Genome Sequencing and Analysis of BCG Vaccine Strains

(2013) Wen Zhang et al.   PLoS One

Exploiting the mycobacterial cell wall to design improved vaccines against tuberculosis

(2013) Matteo Morandi et al.   Journal of Infection in Developing Countries

Nonprotein Structures from Mycobacteria: Emerging Actors for Tuberculosis Control

(2012) Luz M. Lopez-Marin   Clinical & Developmental Immunology

Prime-boost BCG vaccination with DNA vaccines based in β-defensin-2 and mycobacterial antigens ESAT6 or Ag85B improve protection in a tuberculosis experimental model

(2012) Alberto R. Cervantes-Villagrana et al.   VACCINE

Genome Sequence of Mycobacterium bovis BCG Moreau, the Brazilian Vaccine Strain against Tuberculosis

(2011) L. H. F. Gomes et al.   JOURNAL OF BACTERIOLOGY

Tuberculosis vaccines: beyond bacille Calmette-Guerin

(2011) H. McShane   PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES

Proteoliposomes from Mycobacterium smegmatis induce immune cross-reactivity against Mycobacterium tuberculosis antigens in mice

(2011) Lissete Rodriguez et al.   VACCINE

Confronting the scientific obstacles to global control of tuberculosis

(2008) Douglas B. Young et al.   JOURNAL OF CLINICAL INVESTIGATION

A proteoliposome based formulation administered by the nasal route produces vibriocidal antibodies against El Tor Ogawa Vibrio cholerae O1 in BALB/c mice

(2008) José Luis Pérez et al.   VACCINE